Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 AlteredExpression BEFREE α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer. 27065319

2016

Entrez Id: 1137
Gene Symbol: CHRNA4
CHRNA4
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 Biomarker BEFREE α*-conotoxins that targeted either α9α10 or α3β4 nAChR were able to significantly inhibit cervical cancer cell proliferation. 31035425

2019

Entrez Id: 4318
Gene Symbol: MMP9
MMP9
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker BEFREE ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer. 19996286

2010

Entrez Id: 6424
Gene Symbol: SFRP4
SFRP4
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 Biomarker BEFREE ZAR1 and SFRP4 qMSP could be used as potential biomarker for CC diagnosis. 24787227

2014

Entrez Id: 9365
Gene Symbol: KL
KL
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.040 AlteredExpression BEFREE Yet, the expression pattern of klotho in cervical cancer has not been determined. 26209729

2016

Entrez Id: 285
Gene Symbol: ANGPT2
ANGPT2
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.020 AlteredExpression BEFREE Wound closure assay and Transwell assay showed that upregulated or downregulated Ang-1 and Ang-2 expression promoted or reduced cervical cancer cell lines migration and invasion, respectively. 28720059

2017

Entrez Id: 738
Gene Symbol: VPS51
VPS51
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 AlteredExpression BEFREE Wound closure assay and Transwell assay showed that upregulated or downregulated Ang-1 and Ang-2 expression promoted or reduced cervical cancer cell lines migration and invasion, respectively. 28720059

2017

Entrez Id: 284
Gene Symbol: ANGPT1
ANGPT1
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.020 AlteredExpression BEFREE Wound closure assay and Transwell assay showed that upregulated or downregulated Ang-1 and Ang-2 expression promoted or reduced cervical cancer cell lines migration and invasion, respectively. 28720059

2017

Entrez Id: 7108
Gene Symbol: TM7SF2
TM7SF2
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 AlteredExpression BEFREE Wound closure assay and Transwell assay showed that upregulated or downregulated Ang-1 and Ang-2 expression promoted or reduced cervical cancer cell lines migration and invasion, respectively. 28720059

2017

Entrez Id: 4360
Gene Symbol: MRC1
MRC1
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.040 GeneticVariation BEFREE Women with MMR gene mutations were found to have an increased risk of cervical cancer. 26077226

2015

Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker BEFREE Women seen at Pérola Byington Hospital, São Paulo, Brazil, with histologically confirmed cervicitis (n = 31), cervical intraepithelial neoplasia (CIN) 1 (n = 30), CIN 2,3 (n = 30), and cervical cancer (n = 7) had also cervical material collected for liquid-based cytology, human papillomavirus Hybrid Capture 2 (HC2) test, and p16 and FHIT immunohistochemical reactions. 17596760

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker BEFREE Women seen at Pérola Byington Hospital, São Paulo, Brazil, with histologically confirmed cervicitis (n = 31), cervical intraepithelial neoplasia (CIN) 1 (n = 30), CIN 2,3 (n = 30), and cervical cancer (n = 7) had also cervical material collected for liquid-based cytology, human papillomavirus Hybrid Capture 2 (HC2) test, and p16 and FHIT immunohistochemical reactions. 17596760

2007

Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker BEFREE WNT2 overexpression in cervical cancer was associated with β-catenin activation and induction of EMT, which further contributed to metastasis in cervical cancer. 27513465

2016

Entrez Id: 406908
Gene Symbol: MIR124-2
MIR124-2
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.030 PosttranslationalModification BEFREE Within screening round capability of FAM19A4/mir124-2 methylation to detect cervical cancer was 100% (11/11, 95% CI: 71.5-100). 29663363

2018

Entrez Id: 151647
Gene Symbol: TAFA4
TAFA4
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.060 PosttranslationalModification BEFREE Within screening round capability of FAM19A4/mir124-2 methylation to detect cervical cancer was 100% (11/11, 95% CI: 71.5-100). 29663363

2018

Entrez Id: 442900
Gene Symbol: MIR326
MIR326
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.040 Biomarker BEFREE WITHDRAWN: LncRNA-HOTAIR Activates Tumor Cell Proliferation and Migration by Suppressing MiR-326 in Cervical Cancer. 28893349

2017

Entrez Id: 3385
Gene Symbol: ICAM3
ICAM3
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.020 Biomarker BEFREE With these observations, we can suggest that an increased expression of ICAM-3 is associated with radiation resistance in cervical cancer cells and the expression of ICAM-3 can be used as a valuable biomarker to predict the radiation resistance in cervical cancer that occurs during radiotherapy. 15880373

2005

Entrez Id: 724025
Gene Symbol: MIR655
MIR655
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 AlteredExpression BEFREE With the hybridization method, eight microRNAs (miR-9-5p, miR-136-5p, miR-148a-3p, miR-190a-5p, miR-199b-5p, miR-382-5p, miR-597-5p, and miR-655-3p) were found to be expressed differently in the HPV16-positive cervical cancer group and HPV16-positive normal group (fold change ≥ 2). 30627542

2018

Entrez Id: 8651
Gene Symbol: SOCS1
SOCS1
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.080 Biomarker BEFREE With reduced transformation activity and enhanced antigenicity, a modified HPV16 E7 (HPV16mE7) was used to load DCs with silenced SOCS1 mediated by a recombinant adenovirus to improve the targetability and efficiency against cervical cancer. 27754760

2017

Entrez Id: 1508
Gene Symbol: CTSB
CTSB
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 AlteredExpression BEFREE With Q-PCR and Western blotting, we observed cathepsin B expression in cervical cancer cell line Hela cells. 22127599

2012

Entrez Id: 6891
Gene Symbol: TAP2
TAP2
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.060 Biomarker BEFREE With logistic modeling, the markers that showed consistent association with the occurrence of cervical cancer were TAP2 A/B, HLA-DR2 1501, and TAP1 C/C. 12648582

2003

Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 AlteredExpression BEFREE Whole Lesion Histogram Analysis Derived From Morphological MRI Sequences Might be Able to Predict EGFR- and Her2-Expression in Cervical Cancer. 30318289

2019

Entrez Id: 1956
Gene Symbol: EGFR
EGFR
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker BEFREE Whole Lesion Histogram Analysis Derived From Morphological MRI Sequences Might be Able to Predict EGFR- and Her2-Expression in Cervical Cancer. 30318289

2019

Entrez Id: 3342
Gene Symbol: HTC2
HTC2
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.040 GeneticVariation BEFREE Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines. 17096350

2007

Entrez Id: 6774
Gene Symbol: STAT3
STAT3
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.100 Biomarker BEFREE While, inhibition of miR-29b could prevent the cisplatin-induced epithelial features, cell movement and angiogenesis of CC cells, which means miR-29b/STAT3 axis participates in the chemotherapy of cisplatin in CC. 28122338

2017